VAXX insider filings
Vaxxinity, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2024-04-29. Screen VAXX transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for VAXX between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — Vaxxinity, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2024-04-29 | 4 | Ray Sumita — Chief Legal, Comp & Admin Off | Grant/award (A): 425,000 (derivative) @ $0 | EDGAR |
| 2023-11-03 | 4 | Paula Molina Rene — See Remarks | Holdings only — no transactions reported | EDGAR |
| 2023-10-11 | 4 | Powchik Peter — Director | Grant/award (A): 159,744 (derivative) @ $0 | EDGAR |
| 2023-09-08 | 4 | Prime Movers Lab Fund I LP — 10% owner Sloss Dakin — 10% owner | Sale (S): 1,251 @ $1.88 · Sale (S): 5,308 @ $1.88 · Sale (S): 507 @ $1.88 · Sale (S): 892 @ $1.88 · Sale (S): 2,189 @ $1.88 · Sale (S): 4,786 @ $1.79 · +9 more | EDGAR |
| 2023-06-26 | 4 | Smith James Alan — Director | Grant/award (A): 132,352 (derivative) @ $0 | EDGAR |
| 2023-06-26 | 4 | Ogilvie Landon E — Director | Grant/award (A): 132,352 (derivative) @ $0 | EDGAR |
| 2023-06-26 | 4 | Eade Katherine A. — Director | Grant/award (A): 132,352 (derivative) @ $0 | EDGAR |
| 2023-06-26 | 4 | Diamandis Peter — Director | Grant/award (A): 132,352 (derivative) @ $0 | EDGAR |
| 2023-06-26 | 4 | Powchik Peter — Director | Grant/award (A): 132,352 (derivative) @ $0 | EDGAR |
| 2023-06-26 | 4 | TOLEDANO GABRIELLE B — Director | Grant/award (A): 132,352 (derivative) @ $0 | EDGAR |
| 2023-06-26 | 4 | HORNIG GEORGE R — Director | Grant/award (A): 132,352 (derivative) @ $0 | EDGAR |
| 2023-05-02 | 4 | Diamandis Peter — Director | Option exercise (M): 429,037 @ $0.57 · Option exercise (M): 46,500 @ $1.21 · Option exercise (M): 429,037 (derivative) @ $0 · Option exercise (M): 46,500 (derivative) @ $0 | EDGAR |
| 2023-04-05 | 4 | Hu Mei Mei — See Remarks, Director, 10% owner | Grant/award (A): 620,000 (derivative) @ $0 · Grant/award (A): 73,928 (derivative) @ $0 | EDGAR |
| 2023-04-05 | 4 | Reese Lou — See Remarks, Director | Grant/award (A): 620,000 (derivative) @ $0 · Grant/award (A): 61,607 (derivative) @ $0 · Grant/award (A): 301,188 (derivative) @ $0 | EDGAR |
| 2023-04-04 | 4 | Pesile Jason — See Remarks | Grant/award (A): 32,700 (derivative) @ $0 | EDGAR |
| 2023-04-04 | 4 | Paula Molina Rene — See Remarks | Grant/award (A): 116,612 (derivative) @ $0 | EDGAR |
| 2023-04-04 | 4 | Palm Ulo — See Remarks | Grant/award (A): 123,418 (derivative) @ $0 | EDGAR |
| 2023-01-25 | 4 | Prime Movers Lab Fund I LP — 10% owner Sloss Dakin — 10% owner | Sale (S): 95,475 @ $3.35 · Sale (S): 405,217 @ $3.35 | EDGAR |
| 2022-12-05 | 4 | Prime Movers Lab Fund I LP — 10% owner Sloss Dakin — 10% owner | Sale (S): 63,843 @ $2.97 · Sale (S): 270,964 @ $2.97 · Sale (S): 2,620 @ $2.57 · Sale (S): 11,121 @ $2.57 | EDGAR |
| 2022-09-08 | 4 | Prime Movers Lab Fund I LP — 10% owner Sloss Dakin — 10% owner | Sale (S): 5,947 @ $2.40 · Sale (S): 2,234 @ $2.40 · Sale (S): 3,934 @ $2.40 · Sale (S): 25,243 @ $2.40 | EDGAR |
| 2022-08-29 | 4 | Guirakhoo Farshad — (Former) Chief Scientific Off. | Option exercise (M): 10,000 @ $0.57 · Option exercise (M): 20,000 @ $0.57 · Option exercise (M): 26,005 @ $0.57 · Option exercise (M): 2,640 @ $0.57 · Option exercise (M): 10,000 (derivative) @ $0 · Option exercise (M): 20,000 (derivative) @ $0 · +2 more | EDGAR |
| 2022-08-25 | 4 | Prime Movers Lab Fund I LP — 10% owner Sloss Dakin — 10% owner | Sale (S): 7,960 @ $2.45 · Sale (S): 2,990 @ $2.45 · Sale (S): 5,265 @ $2.45 · Sale (S): 33,785 @ $2.45 · Sale (S): 19,741 @ $2.39 · Sale (S): 7,415 @ $2.39 · +6 more | EDGAR |
| 2022-06-23 | 4 | Chui James — Director | Grant/award (A): 129,187 (derivative) @ $0 | EDGAR |
| 2022-06-23 | 4 | Diamandis Peter — Director | Grant/award (A): 129,187 (derivative) @ $0 | EDGAR |
| 2022-06-23 | 4/A | Diamandis Peter — Director | Tax withholding (F): 312,659 @ $8.60 | EDGAR |
| 2022-06-23 | 4/A | Diamandis Peter — Director | Sale (S): 248 @ $13 | EDGAR |
| 2022-06-23 | 4/A | Diamandis Peter — Director | Conversion (C): 13,824 · Conversion (C): 13,824 · Conversion (C): 21,511 (derivative) | EDGAR |
| 2022-06-23 | 4 | Powchik Peter — Director | Grant/award (A): 129,187 (derivative) @ $0 | EDGAR |
| 2022-06-23 | 4 | BLATT GREGORY R — Director | Grant/award (A): 129,187 (derivative) @ $0 | EDGAR |
| 2022-06-23 | 4 | HORNIG GEORGE R — Director | Grant/award (A): 129,187 (derivative) @ $0 | EDGAR |
| 2022-06-21 | 4 | Reese Lou — Executive Chairman, Director, 10% owner | Purchase (P): 100,000 @ $1.99 | EDGAR |
| 2022-06-21 | 4 | Hu Mei Mei — See Remarks, Director, 10% owner | Purchase (P): 100,000 @ $1.99 | EDGAR |
| 2022-06-21 | 4 | UNITED BIOMEDICAL INC — 10% owner | Purchase (P): 100,000 @ $1.99 | EDGAR |
| 2022-06-14 | 4 | Prime Movers Lab Fund I LP — 10% owner Sloss Dakin — 10% owner | Sale (S): 6,687 @ $2.80 · Sale (S): 2,512 @ $2.80 · Sale (S): 4,423 @ $2.80 · Sale (S): 28,378 @ $2.80 · Sale (S): 21,811 @ $2.43 · Sale (S): 8,193 @ $2.43 · +2 more | EDGAR |
| 2022-06-10 | 4 | UNITED BIOMEDICAL INC — 10% owner | Purchase (P): 10,000 @ $2.95 · Purchase (P): 10,978 @ $2.72 | EDGAR |
| 2022-06-10 | 4 | Hu Mei Mei — See Remarks, Director, 10% owner | Purchase (P): 10,000 @ $2.95 · Purchase (P): 10,978 @ $2.72 | EDGAR |
| 2022-06-10 | 4 | Reese Lou — Executive Chairman, Director, 10% owner | Purchase (P): 10,000 @ $2.95 · Purchase (P): 10,978 @ $2.72 | EDGAR |
| 2022-05-05 | 4 | Guirakhoo Farshad — Chief Scientific Officer | Option exercise (M): 10,000 @ $0.57 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2022-04-28 | 4 | UNITED BIOMEDICAL INC — 10% owner | Purchase (P): 18,105 @ $3.45 · Purchase (P): 4,807 @ $3.58 | EDGAR |
| 2022-04-28 | 4 | Reese Lou — Executive Chairman, Director | Purchase (P): 18,105 @ $3.45 · Purchase (P): 4,807 @ $3.58 | EDGAR |
| 2022-04-28 | 4 | Hu Mei Mei — See Remarks, Director, 10% owner | Purchase (P): 18,105 @ $3.45 · Purchase (P): 4,807 @ $3.58 | EDGAR |
| 2022-04-27 | 4 | Hu Mei Mei — See Remarks, Director, 10% owner | Purchase (P): 8,038 @ $3.37 | EDGAR |
| 2022-04-27 | 4 | Reese Lou — Executive Chairman, Director | Purchase (P): 8,038 @ $3.37 | EDGAR |
| 2022-04-27 | 4 | UNITED BIOMEDICAL INC — 10% owner | Purchase (P): 8,038 @ $3.37 | EDGAR |
| 2022-04-04 | 4 | Powchik Peter — Director | Grant/award (A): 94,186 (derivative) @ $0 | EDGAR |
| 2022-03-15 | 4 | Palm Ulo — Chief Medical Officer | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2022-01-26 | 4 | Diamandis Peter — Director | Option exercise (M): 652,764 @ $4.12 · Option exercise (M): 652,764 (derivative) @ $0 | EDGAR |
| 2022-01-11 | 4 | Pesile Jason — See Remarks | Grant/award (A): 51,225 (derivative) @ $0 | EDGAR |
| 2022-01-06 | 4 | Chui James — Director | Purchase (P): 6,000 @ $5.48 | EDGAR |
| 2022-01-05 | 4 | HORNIG GEORGE R — Director | Grant/award (A): 67,953 (derivative) @ $0 | EDGAR |
Recent 8-K events — Vaxxinity, Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2024-04-19 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-03-14 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2024-02-15 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2023-12-01 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2023-09-28 | 8-K | 4.01 — Changes in Registrant's Certifying Accountant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8.01 — Other Events | EDGAR |
| 2023-07-27 | 8-K | 4.01 — Changes in Registrant's Certifying Accountant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-06-22 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2023-02-03 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-06-24 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-03-28 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=VAXX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs